EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly

Mette H Jensen iD, Lærke S Gasbjerg iD, Kirsa Skov-Jeppesen, Jens C B Jacobsen, Steen S Poulsen, Cuiqi Zhou, Ruta Jakubauskaite, Frantz R Poulsen, Christian Bonde, Mahmoud Albarazi, Bo Halle, Charlotte B Christiansen und 16 weitere

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae583 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Mette H Jensen und 27 weiteren Autor:innen. Beteiligte Einrichtung: Antag Therapeutics Aps, 2200 Copenhagen, Denmark. Hauptthemen laut MEDLINE: Receptors, Gastrointestinal Hormone, Acromegaly, Gastric Inhibitory Polypeptide, Human Growth Hormone. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovation Fund Denmark, Antag Therapeutics Aps, Augustinus Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

About 30% of patients with active acromegaly experience paradoxically increased growth hormone (GH) secretion during the diagnostic oral glucose tolerance test (OGTT). Endogenous glucose-dependent insulinotropic polypeptide (GIP) is implicated in this paradoxical secretion.

Objective

We used the GIP receptor (GIPR) antagonist GIP(3-30)NH2 to test the hypothesis that GIP mediates this paradoxical response when GIPR is abundantly expressed in somatotropinomas.

Methods

A total of 25 treatment-naive patients with acromegaly were enrolled. Each patient underwent one OGTT during simultaneous placebo infusion and one OGTT during a GIP(3-30)NH2 infusion. Blood samples were drawn at baseline and regularly after infusions to measure GH. We assessed pituitary adenoma size by magnetic resonance imaging and GIPR expression by immunohistochemistry on resected somatotropinomas. For mechanistic confirmation, we applied in vitro and ex vivo approaches. The main outcome measure was the effect of GIP(3-30)NH2 on paradoxical GH secretion during OGTT as a measure of GIP involvement.

Results

In 4 of 7 patients with paradoxical GH secretion, GIP(3-30)NH2 infusion completely abolished the paradoxical response (P = .0003). Somatotrophs were available from 3 of 4 of these patients, all showing abundant GIPR expression. Adenoma size did not differ between patients with and without paradoxical GH secretion.

Conclusion

Of 25 patients with acromegaly, 7 had paradoxical GH secretion during OGTT, and pharmaceutical GIPR blockade abolished this secretion in 4. Corresponding somatotroph adenomas abundantly expressed GIPR, suggesting a therapeutic target in this subpopulation of patients. In vitro and ex vivo analyses confirmed the role of GIP and the effects of the antagonist.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Gastrointestinal HormoneAcromegalyGastric Inhibitory PolypeptideHuman Growth HormoneGrowth Hormone-Secreting Pituitary AdenomaPeptide FragmentsHumansMaleFemaleMiddle AgedAdultAdenomaGlucose Tolerance TestAged

Stichwörter der Autor:innen

GIP receptor antagonismacromegalyglucose-dependent insulinotropic polypeptide (GIP)growth hormone (GH)paradoxical GH secretion

Substanzen

gastric inhibitory polypeptide receptorReceptors, Gastrointestinal HormoneGastric Inhibitory PolypeptideHuman Growth HormonePeptide Fragmentsgastric inhibitory polypeptide (3-30)-amide

Autor:innen und Institutionen

  • Antag Therapeutics Aps, 2200 Copenhagen, Denmark.
  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Pituitary Center, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Department of Radiology, Copenhagen University Hospital Rigshospitalet, 2100 Copenhagen, Denmark.
  • Department of Neurosurgery, Odense University Hospital, 5000 Odense, Denmark.
  • Department of Endocrinology and Internal Medicine, Aarhus University Hospital, 8200 Aarhus, Denmark.

ORCID-Profile: Mette H Jensen, Lærke S Gasbjerg, Bjørn Hoe, Flemming Dela, Shlomo Melmed, Bolette Hartmann, Ulla Feldt-Rasmussen, Mette M Rosenkilde

Förderung

  • Innovation Fund Denmark
  • Antag Therapeutics Aps
  • Augustinus Fonden
  • Læge Sofus Carl Emil Friis og hustru Olga Doris Friis' Legat
  • Læge Sofus Carl Emil Friis og hustru Olga Doris Friis’ Legat

Zitieren

APA

Jensen, M. H., Gasbjerg, L. S., Skov-Jeppesen, K., Jacobsen, J. C. B., Poulsen, S. S., Zhou, C., Jakubauskaite, R., Poulsen, F. R., Bonde, C., Albarazi, M., Halle, B., Christiansen, C. B., Sanni, S. J., Byberg, S., Hoe, B., Holst, J. J., Dela, F., Rasmussen, A. K., Knop, F. K., …, & Rosenkilde, M. M. (2025). GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae583

Vancouver

Jensen MH, Gasbjerg LS, Skov-Jeppesen K, Jacobsen JCB, Poulsen SS, Zhou C, et al. GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae583

BibTeX
@article{Jensen2025,
  author = {Jensen, Mette H and Gasbjerg, Lærke S and Skov-Jeppesen, Kirsa and Jacobsen, Jens C B and Poulsen, Steen S and Zhou, Cuiqi and Jakubauskaite, Ruta and Poulsen, Frantz R and Bonde, Christian and Albarazi, Mahmoud and Halle, Bo and Christiansen, Charlotte B and Sanni, Samra J and Byberg, Sarah and Hoe, Bjørn and Holst, Jens J and Dela, Flemming and Rasmussen, Aase K and Knop, Filip K and Arlien-Søborg, Mai C and Melmed, Shlomo and Jørgensen, Jens Otto L and Andersen, Marianne S and Hartmann, Bolette and Klose, Marianne C and Feldt-Rasmussen, Ulla and Sparre-Ulrich, Alexander H and Rosenkilde, Mette M},
  title = {GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae583}
}
Kostenlos starten →